Recommendations on occupational radiation protection in interventional cardiology

 

The evolution in experience of the operators together with the continuous improvement of devices have allowed new procedures that we did not perform a few years ago and that we never imagined possible, not even for the most enthusiastic of interventional cardiologists.

Not a huge intellectual effort is required to say that the future will continue inexorably in the same direction. The same is happening in other specialties besides cardiology where surgery is being performed on increasingly complex cases.

However, it is logical that the progresses of science are not all positive news. More complex procedures take longer and automatically have higher radiation doses not only for the patient but also for medical and non-medical operators in the room.

In this sense, we believe it’s beneficial to highlight our concern about this issue in a multi-disciplinary framework group dedicated to radiation protection in interventional cardiology within the International Atomic Energy Agency (IAEA) based in Vienna, Austria. Writing about “Recommendations on occupational radiation protection in interventional cardiology”, it was decided to focus in the first instance on professional care and leave care of the patient until later.

We tried to write a practical approach where operators and ward staff can identify the most useful radiation protection measures and hope that their knowledge will influence an adequate prevention of stochastic as well as deterministic effects in the future. It gave us real satisfaction when a prestigious magazine, “Catheterization and Cardiovascular Interventions”, accepted our work for publication and, as such, we want to share this with all SOLACI partners.

Dr. Ariel Durán, FACC
SOLACI Radiation Safety Committee

recomendaciones_proteccion_radiologica
Ariel Durán

More articles by this author

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...

CRT 2026 | Clopidogrel vs Aspirin as Long-Term Monotherapy After Coronary Angioplasty

The use of aspirin as chronic antiplatelet therapy after percutaneous coronary intervention (PCI) has historically been the standard recommended by international guidelines. However, recent...

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

CRT 2026 | NAVITOR IDE: Hemodynamic Outcomes and 5-Year Durability of an Intra-Annular Self-Expanding Transcatheter Aortic Valve

As TAVI expands into younger populations and patients with lower surgical risk, prosthesis durability has become a key aspect of long-term management. The NAVITOR...

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...